Clinical Trial Update: Blood Samples to Identify Biomarkers of Busulfan

View source ↗

Summary

A terminated clinical trial at Fred Hutchinson Cancer Center investigated using blood samples to identify biomarkers of busulfan exposure. The study included pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Lymphoma | Status: TERMINATED